A Randomised Trial of Artekin and Artesunate & Amodiaquine for Uncomplicated Malaria in Timika, Papua, Indonesia.
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The primary aim of the comparative trial is to assess the relative safety and efficacy of two
artemisinin containing regimens: amodiaquine plus artesunate (AAQ) and artekin both
administered once daily for 3 days.
Phase:
N/A
Details
Lead Sponsor:
Menzies School of Health Research
Collaborators:
National Health and Medical Research Council, Australia National Institute of Health Research and Development, Ministry of Health Republic of Indonesia Wellcome Trust